These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 10550559)

  • 1. Intracellular expression of CD61 precedes surface expression.
    Käfer G; Willer A; Ludwig W; Krämer A; Hehlmann R; Hastka J
    Ann Hematol; 1999 Oct; 78(10):472-4. PubMed ID: 10550559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD34+ megakaryoblastic leukaemic cells are CD38-, but CD61+ and glycophorin A+: improved criteria for diagnosis of AML-M7?
    Helleberg C; Knudsen H; Hansen PB; Nikolajsen K; Kjaersgaard E; Ralfkiaer E; Johnsen HE
    Leukemia; 1997 Jun; 11(6):830-4. PubMed ID: 9177436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of cell marker analysis in de novo acute myeloid leukemia.
    Del Poeta G; Stasi R; Venditti A; Suppo G; Aronica G; Bruno A; Masi M; Tabilio A; Papa G
    Leukemia; 1994 Mar; 8(3):388-94. PubMed ID: 7907393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunophenotype of Down syndrome acute myeloid leukemia and transient myeloproliferative disease differs significantly from other diseases with morphologically identical or similar blasts.
    Langebrake C; Creutzig U; Reinhardt D
    Klin Padiatr; 2005; 217(3):126-34. PubMed ID: 15858703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of CD13 and CD33 surface antigen-negative acute myeloid leukemia.
    Kraguljac N; Marisavljevic D; Jankovic G; Radosevic N; Pantic M; Donfrid M; Miletic N; Boskovic D; Colovic M
    Am J Clin Pathol; 2000 Jul; 114(1):29-34. PubMed ID: 10884796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunophenotypic significance of the "lymphoid" CD38 antigen in myeloid blood malignancies.
    Marinov J; Koubek K; Starý J
    Neoplasma; 1993; 40(6):355-8. PubMed ID: 8289967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myeloid enzymes profile related to the immunophenotypic characteristics of blast cells from patients with acute myeloid leukemia (AML) at diagnosis.
    Klobusicka M; Kusenda J; Babusikova O
    Neoplasma; 2005; 52(3):211-8. PubMed ID: 15875082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The immunophenotype of adult acute myeloid leukemia: high frequency of lymphoid antigen expression and comparison of immunophenotype, French-American-British classification, and karyotypic abnormalities.
    Khalidi HS; Medeiros LJ; Chang KL; Brynes RK; Slovak ML; Arber DA
    Am J Clin Pathol; 1998 Feb; 109(2):211-20. PubMed ID: 9583894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Flow cytometric analysis of myeloperoxidase negative acute unclassifiable leukemias by monoclonal antibodies. Acute myelogenous and acute megakaryocytic leukemia].
    Imamura N; Kuramoto A; Kawaguchi Y; Tanaka R
    Rinsho Ketsueki; 1989 Jan; 30(1):11-21. PubMed ID: 2541276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymphoid-associated antigen expression by acute myeloid leukemia.
    Launder TM; Bray RA; Stempora L; Chenggis ML; Farhi DC
    Am J Clin Pathol; 1996 Aug; 106(2):185-91. PubMed ID: 8712171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukins and colony stimulating factors in human myeloid leukemia cell lines.
    Hassan HT; Drexler HG
    Leuk Lymphoma; 1995 Dec; 20(1-2):1-15. PubMed ID: 8750618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lineage identification of acute leukemias: relevance of immunologic and ultrastructural techniques.
    Stasi R; Del Poeta G; Venditti A; Bruno A; Suppo G; Aronica G; Di Carlo G; Papa G
    Hematol Pathol; 1995; 9(2):79-94. PubMed ID: 7559258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute myeloid leukaemia with an unusual phenotype: myeloperoxidase (+), CD13 (-), CD14 (-) and CD33 (-).
    Seshi B; Kashyap A; Bennett JM
    Br J Haematol; 1992 Jul; 81(3):374-7. PubMed ID: 1382546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pan myeloid antigen-negative pediatric acute megakaryoblastic leukemia.
    Cetin N; Lorsbach RB
    Pediatr Blood Cancer; 2014 Nov; 61(11):2089-91. PubMed ID: 24962432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytochemical profile of megakaryoblastic leukaemia: a study with cytochemical methods, monoclonal antibodies, and ultrastructural cytochemistry.
    Pombo De Oliveira MS; Gregory C; Matutes E; Parreira A; Catovsky D
    J Clin Pathol; 1987 Jun; 40(6):663-9. PubMed ID: 3038965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intracellular markers in acute myeloid leukemia diagnosis.
    Koníková E; Glasová M; Kusenda J; Babusíková O
    Neoplasma; 1998; 45(5):282-91. PubMed ID: 9921916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics of a cell line established from a case of acute megakaryoblastic leukemia.
    Skinnider LF; Pabello P; Zheng CY
    Acta Haematol; 1997; 98(1):26-31. PubMed ID: 9210910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of CD9 and CD61 for the characterization of AML-M7 by flow cytometry in a dog*.
    Valentini F; Tasca S; Gavazza A; Lubas G
    Vet Comp Oncol; 2012 Dec; 10(4):312-8. PubMed ID: 22235968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Immunologic characteristics and prognosis of acute myeloid leukemia M1].
    Zhao F; Chen Y
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Aug; 15(4):687-91. PubMed ID: 17708783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD7 expression in acute myeloid leukemia.
    Del Poeta G; Stasi R; Venditti A; Cox C; Aronica G; Masi M; Bruno A; Simone MD; Buccisano F; Papa G
    Leuk Lymphoma; 1995 Mar; 17(1-2):111-9. PubMed ID: 7539657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.